Chai Discovery 夏签四单，Bio×AI 工具获药企买单
🔬The BioAI Phase Shift - Matthew McPartlon & Neil Patil, Chai Discovery
Chai 一个夏天签了四单药企合作，想知道 Bio×AI 怎么赚钱的，听两位核心人物亲口讲。
Chai Discovery 是一家专注生物与 AI 交叉领域的公司，今年夏天已与药企达成四笔合作交易。联合创始人 Matt McPartlon 和产品负责人 Neil Patil 在访谈中解释了药企为何突然愿意为 Bio×AI 工具付费。
他们指出，Chai 的 AI 模型能加速药物发现流程，降低研发成本，这是吸引药企的关键。访谈还探讨了生物 AI 工具在制药行业的实际应用场景与商业前景。
🔬The BioAI Phase Shift - Matthew McPartlon & Neil Patil, Chai Discovery
Pharma is suddenly paying for Bio × AI tools, and Chai is leading the pack with four deals closed this summer. Cofounder Matt McPartlon and Product leader Neil Patil explain why.
This report is categorized under AITOP's "Industry" desk. Key entities and technical topics under continuous tracking include Chai Discovery, BioAI, 药物发现, AI制药.
Source attribution: curated from Latent Space (swyx) (@RJ Honicky).
